Search
for
Sort by
Research 751–780 of 1000+
- Hydroxychloroquine and Chloroquine in Prophylaxis and Treatment of COVID-19
- Impact of Telemedicine on Health Expenditures During the COVID-19 Pandemic in Japan: Quasi-Experimental Study
- Can the golden nutraceutical frankincense combat COVID‐19?
- Elevated neutralization of Omicron with sera of COVID-19 recovered and breakthrough cases vaccinated with Covaxin than two dose naïve vaccinees
- The brief overview, antivirus and anti-SARS-CoV-2 activity, quantitative methods, and pharmacokinetics of cepharanthine: a potential small-molecule drug against COVID-19
- Knowledge, Attitude, and Practice Regarding COVID-19 Skin Manifestations among Doctors Working at Khartoum Dermatology and Venereology Teaching Hospital, 2021
- Online search interest in long-term symptoms of coronavirus disease 2019 during the COVID-19 pandemic in Japan: Infodemiology study using the most visited search engine in Japan
- Immune mechanisms associated with sex-based differences in severe COVID-19 clinical outcomes
- The Need for Speed and Efficiency: A Brief Review of Small Molecule Antivirals for COVID-19
- The Impact of Immune-Modifying Treatments for Skin Diseases on the Immune Response to COVID-19 Vaccines: a Narrative Review
- Contract cheating websites in Spain (2019–2024): web traffic trends during COVID-19 and the rise of generative AI
- Drug Repositioning: New Approaches and Future Prospects for Life-Debilitating Diseases and the COVID-19 Pandemic Outbreak
- Corona With Lyme: A Long COVID Case Study
- New onset of alopecia areata in a patient with SARS‐CoV‐2 infection: Possible pathogenetic correlations?
- Risk factors and early preventive measures for long COVID in non-hospitalized patients: analysis of a large cohort in the United Arab Emirates
- How Coronavirus Disease 2019 Changed Dermatology Practice in 1 Year Around the World
- Telogen Effluvium after SARS-CoV-2 Infection: A Series of Cases and Possible Pathogenetic Mechanisms
- Telogen effluvium in the new SARS‐CoV‐2 era
- Eflúvio telógeno como sintoma da “Covid longa” em pacientes pré-infectados por SARS-CoV-2: uma revisão integrativa de literatura
- The shifting preferences of patients and physicians in nonsurgical hair loss treatment
- Data-driven analysis to understand long COVID using electronic health records from the RECOVER initiative
- Reversal of Stress-Associated Alopecia.
- Prevalence and Clinical Characteristics of Androgenetic Alopecia in Nepalese Patients: A Cross-sectional Observational Study
- Characterizing Loss of Response Occurring in a Small Number of Patients During 3 Years of Long-Term Maintenance Therapy with Baricitinib 4-mg: Results From BRAVE-AA1 and -AA2 Trials
- Epidemiological Analysis of Alopecia in Migrant Communities at Dr. Hair™ Clinics
- Features of hemorheological disorders in patients with alopecia associated with coronavirus infection
- New Onset of Hair Loss Disorders During the Coronavirus Disease 2019 Pandemic: A Korean Nationwide Population-Based Study
- A Study of the Clinical Patterns of Hair Loss in Female Patients
- The Possible Role of Antibodies in Alopecia: A Narrative Review
- Red LED light therapy for telogen effluvium in the course of long COVID in patients with and without androgenetic alopecia